Clinical characteristics, outcomes and risk factors for mortality in hospitalized diabetes and chronic kidney disease patients after COVID-19 infection following widespread vaccination

被引:0
作者
Y. Zou
C. Qin
Q. Yang
Y. Lang
K. Liu
F. Yang
X. Li
Y. Zhao
T. Zheng
M. Wang
R. Shi
W. Yang
Y. Zhou
L. Chen
Fang Liu
机构
[1] West China Hospital of Sichuan University,Division of Nephrology
[2] Southwest Medical University,Department of Clinical Medicine
[3] West China Hospital of Sichuan University,Department of Clinical Research Management
[4] West China Hospital of Sichuan University,Information Center
[5] Engineering Research Center of Medical Information Technology,Division of Project Design and Statistics
[6] Ministry of Education,Integrated Care Management Center
[7] West China Hospital of Sichuan University,Division of Neurology
[8] West China Hospital of Sichuan University,undefined
[9] West China Hospital of Sichuan University,undefined
来源
Journal of Endocrinological Investigation | 2024年 / 47卷
关键词
Covid-19; Diabetes; Chronic kidney disease; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:619 / 631
页数:12
相关论文
共 14 条
[1]  
D'Marco L(2020)Diabetic kidney disease and COVID-19: the crash of two pandemics Front Med (Lausanne) 7 199-1099
[2]  
Tang N(2020)Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost 18 1094-833
[3]  
Leung C(2020)Clinical features of deaths in the novel coronavirus epidemic in China Rev Med Virol 30 823-1629
[4]  
Holman N(2020)Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Lancet Diabetes Endocrinol 8 1623-416
[5]  
Cai R(2021)Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis Int Urol Nephrol 53 403-c184
[6]  
Leon-Abarca JA(2020)The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: a population-based study Acta Biomed 91 c179-2257
[7]  
Baden LR(2021)Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine N Engl J Med 384 6121-241
[8]  
Khwaja A(2012)KDIGO clinical practice guidelines for acute kidney injury Nephron Clin Pract 120 47-77
[9]  
Galiero R(2022)Association between renal function at Admission and COVID-19 in-hospital mortality in Southern Italy: findings from the prospective multicenter Italian COVOCA study J Clin Med 11 2251-838
[10]  
Jeong HE(2023)Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study BMC Med 21 230-undefined